Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can exert antidepressant,
anti-inflammatory and neuroprotective properties, but the exact molecular mechanism …

Omega-3 polyunsaturated fatty acids (n‐3-PUFAs), mainly eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA), may improve or prevent some psychiatric and …

Accumulating evidence suggests that the pathophysiology of depression might be
associated with neuroinflammation, which could be attenuated by pharmacological …

Brain lipids contain a high proportion of polyunsaturated fatty acids (PUFA), which are a
main component of cell membranes. Omega-3 (ω-3) PUFA eicosapentaeoic acid (EPA) and …

Omega-3 polyunsaturated fatty acids (PUFAs) can play important roles in maintaining
mental health and resistance to stress, and omega-3 PUFAs supplementation can display …

Classically, polyunsaturated fatty acids (PUFA) were largely thought to be relatively inert
structural components of brain, largely important for the formation of cellular membranes …

The unsatisfactory results of monoamine-based antidepressant therapy and the high
occurrence of somatic symptoms and physical illness in patients with depression imply that …

Alzheimer disease (AD) is becoming one of the most prevalent neurodegenerative
conditions worldwide. Although the disease progression is becoming better understood …

The results of several meta-analyses suggest that eicosapentaenoic acid (EPA)
supplementation is therapeutic in managing the symptoms of major depression. It was …

Glucocorticoids have been suggested to be involved in several neuropsychiatric disorders,
including depression. One of the possible mechanisms through which glucocorticoids …